stocrin 600 mg tablets
merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - film coated tablets - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .
ciloxan
novartis israel ltd - ciprofloxacin as hydrochloride - solution - ciprofloxacin as hydrochloride 3 mg/ml - ciprofloxacin - ciprofloxacin - corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. for localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. in this case, a mucopurulent secretion comes through the perforated eardrum. pseudomonas aeruginosa is one of the organisms most likely to be found in this case. also in other infections of the ear in which pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), ciloxan can be used under the strict supervision of an ear specialist. it must be understood that this is not a routine treatment and that improper use must be avoided.
azarga
novartis israel ltd - brinzolamide; timolol as maleate - ophthalmic suspension - brinzolamide 10 mg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intra-ocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.
butrans 5
rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 5 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
butrans 10
rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
butrans 20
rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
betahistine 16mg tablets
arrow generics ltd - betahistine dihydrochloride - oral tablet - 16mg
butrans 15
rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 15 mg - buprenorphine - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.
seroxat
glaxo smith kline (israel) ltd - paroxetine as hydrochloride - coated tablets - paroxetine as hydrochloride 20 mg - paroxetine - treatment of (in adults): major depressive disorder obsessive compulsive disorder (ocd) panic disorder with and without agoraphobia social anxiety disorders/social phobia generalised anxiety disorder post-traumatic stress disorder
minocycline 50 mg
rafa laboratories ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 50 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrier.